Clinical Trial Update: A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating REGN7508 for preventing venous thromboembolism after knee replacement in adults. The study has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• REGN7508

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Venous Thromboembolism | Phase 2 | Status: COMPLETED | Results posted: 2026-03-02